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ABSTRACT Myosin Va (myoVa) is an actin-based intracellular cargo transporter. In vitro experiments have established that
a single myoVa moves processively along actin tracks, but less is known about how this motor operates within cells. Here we
track the movement of a quantum dot (Qdot)-labeled myoVa HMM in COS-7 cells using total internal reﬂectance ﬂuorescence
microscopy. This labeling approach is unique in that it allows myoVa, instead of its cargo, to be tracked. Single-particle analysis
showed short periods (%0.5 s) of ATP-sensitive linear motion. The mean velocity of these trajectories was 604 nm/s and inde-
pendent of the number of myoVa molecules attached to the Qdot. With high time (16.6 ms) and spatial (15 nm) resolution
imaging, Qdot-labeled myoVa moved with sequential 75 nm steps per head, at a rate of 16 s1, similarly to myoVa in vitro. Monte
Carlo modeling suggests that the random nature of the trajectories represents processive myoVa motors undergoing a random
walk through the dense and randomly oriented cortical actin network.INTRODUCTION
Cargo transport from the cell center to the periphery involves
coordination between microtubule- and actin-based motors.
The prevailing view is that kinesin powers long-range move-
ment on microtubules away from the nucleus, followed by
a handoff to myosin Va (myoVa) for local delivery within
the dense actin cortex (1–3). In vitro studies have established
several features of myoVa that may facilitate successful
cargo transport within the cell. The ability of myoVa to
rapidly diffuse long distances along microtubules with no
energy consumption (4,5) would allow it to scan the micro-
tubule and link up with motor-cargo complexes that are
being actively transported by kinesin. Once transferred to
actin, a single myoVa molecule can move processively for
several microns, taking sequential 75 nm steps per head
(~36 nm movement of the molecule’s center of mass), in
a hand-over-hand fashion (6,7). Although the complex actin
cytoskeleton may pose a physical challenge to myoVa trans-
port, the motor’s structural flexibility allows it to adeptly
maneuver through actin-actin intersections and Arp2/3 junc-
tions (4), thus ensuring continuous movement of the cargo to
its final destination. None of these features, most importantly
myoVa’s processivity, have been firmly established to occur
within cells.
Kinesin- and dynein-based intracellular organelle move-
ments on microtubules have been inferred from the ~8 nm
stepwise movements observed during tracking of fluores-
cently labeled peroxisomes or endocytosed quantum dot
(Qdot)-containing vesicles (8–10). Similarly, 36 nm steps
associated with melanosome trafficking have been attributed
to myosin V (2,11). Even though these step sizes are consis-
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0006-3495/09/07/0509/10 $2.00tent with single-motor in vitro data for myoVa (12,13), the
observed movement may originate from complex mechan-
ical interactions between multiple motors, both actin- and
microtubule-based, that exist on a given cargo (14).
To characterize the motion of single myoVa molecules
within a cellular environment and the challenges that are
presented by the complex cytoskeletal meshwork, we intro-
duced Qdot-labeled myoVa heavy meromyosin (HMM) by
pinocytosis into mammalian COS-7 cells. Qdots offer an
advantage over fluorescent dyes in that they are 20 times
brighter and resistant to photobleaching, and can be nontoxic
to cells for periods of up to several days (15). We took
advantage of these fluorescent semiconductor nanocrystals
in this study, as in previous studies (4,5,7), to serve as
both cargo and a label for single myoVa HMM molecules.
With this approach, we were able to use total internal reflec-
tance fluorescence (TIRF) microscopy to directly observe
individual myoVa motors as they transported their Qdot
cargo within the actin cortex.
Using these techniques, we observed sequential 75 nm
steps taken by a single myoV HMM molecule in COS-7
cells, establishing that processive movement occurs within
a cell. Single-particle mean-squared displacement (MSD)
analysis of the trajectories, along with Monte Carlo model
simulations, suggests that the paths reflect the processive
motion of a myoVa motor traveling along an effectively
random cortical actin network. The rate of movement was
the same whether it was measured in vitro and or in the
context of the high viscosity of the cytoplasm, and was inde-
pendent of the number of motors. Our data thus demonstrate
that the most basic biophysical properties associated with
myoVa transport in vitro—namely, its processivity and
ability to navigate actin-actin intersections—are recapitu-
lated within the complex cellular environment.
doi: 10.1016/j.bpj.2009.04.052
510 Nelson et al.FIGURE 1 Osmotic lysis of pinosomes. (A) Under
hypertonic loading conditions, pinosomes in COS-7 cells
are labeled with FITC-dextran (red) and are visible near
the plasma membrane by TIRF microscopy. At this stage,
Qdot:myoVa HMM complexes (green) localize to pino-
somes, producing the yellow colocalization signal. (B)
After lysis of pinosomes by hypotonic shock, FITC-
dextran forms a uniform haze throughout the cytosol of
the cell, whereas Qdot:myoVa conjugates are free and
motile within the cell. Scale bar: 5 mm.MATERIALS AND METHODS
Protein constructs and Qdot conjugation
A mouse myoVa construct, truncated after amino acid 1098 to produce
a double-headed HMM fragment, was tagged at either the N- or C-terminus
with an 88-amino acid biotin ligase recognition sequence (7,16). Using a
Baculovirus/Sf9 cell system, the myosin heavy chain was coexpressed with
calmodulin light chains that were mutated to be calcium-insensitive (CaM
D-all), eliminating the inhibitory effects on myoVa processivity that accom-
panies light chain dissociation (17). A C-terminal FLAG tag on the myosin
heavy chain facilitated protein purification by affinity chromatography (17).
A single-headed myoVa subfragment-1 (S1) construct was generated by
truncation after amino acid 908, which was tagged at the C-terminus with
a biotin ligase recognition sequence and expressed and purified as above.
Purified myoVa was conjugated to either 565 nm or 655 nm emitting
streptavidin-coated Qdots (Invitrogen, Carlsbad, CA) in buffer A (25 mM
imidazole, pH 7.4, 0.3 M KCl, 4 mM MgCl2, 1 mM EGTA, 10 mM
DTT, and 0.1 mg/mL BSA). To ensure that a Qdot was conjugated to a single
motor, Qdots and N-terminal biotin myoVa were mixed at a 5:1 molar ratio
(i.e., 30 mM Qdots to 6 mM myoVa) in buffer A for 10 min at room temper-
ature (25C). Under these conditions and assuming Poisson statistics, 91%
of the Qdots would have no more than one attached motor, and thus the
Qdot would be attached to only one of the two heads. For experiments
focusing on Qdot transport by multiple motors, the mixing ratio was 1:4
with 30 mM Qdots and 120 mM C-terminal biotin-myoVa. This ratio would
produce a mixture with 94% of the Qdots having three or more attached
motors, with binding to the Qdot saturating at four motors based on previous
studies (16).
To confirm that the observed Qdot transport in COS-7 cells resulted from
active myoVa motors, control experiments were performed in which Qdots
were conjugated to either bovine serum albumin (BSA) or chemically modi-
fied myoVa. The BSA-coated Qdots were formed by conjugating 30 mM
streptavidin-Qdots with 150mM biotinylated-BSA (Pierce Biochemical,
Rockford, IL) in buffer A for 10 min at room temperature. Sulfhydryl modi-
fication of expressed myoVa HMM, using N-ethylmaleimide (NEM), re-
sulted in a nonfunctional myoVa that no longer bound actin. NEM stocks
were prepared at 3.75% (w/v) in ethanol and then added to HMM MyoVa
(final concentration 0.1 mg/mL) in 500 mM EGTA, 500 mM sodium azide,Biophysical Journal 97(2) 509–5186.25 mM imidazole. The reaction was allowed to proceed for 5–45 min at
room temperature and then stopped by the addition of 1 M DTT. The lack
of actin binding and the processive movement of NEM-treated myoVa
constructs were determined in the in vitro single-molecule TIRF assay (4,5).
Cell culture studies
COS-7 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)
enriched with 10% (v/v) FBS, with 5% CO2 at 37
C on 35 mm petri dishes
with No. 1 coverglass bottoms (MatTek, Ashland, MA). These cells are
extremely flat and tightly adherent to the coverglass, which makes them
good candidates for TIRF microscopy.
Qdot:MyoVa conjugates were delivered into cells by osmotic lysis of
pinosomes (18,19). Briefly, cells were incubated in hypertonic loading
medium (DMEM with 0.5 M sucrose and 10% w/v poly-ethylene glycol
1000) along with 7.5 nM Qdot:MyoVa conjugates for 10 min at 37C.
The cells were then shocked in hypotonic lysis medium (DMEM and water
in a 3:2 ratio) for 2 min at room temperature. The cells were then returned to
DMEM and imaged at room temperature as described below.
To witness the incorporation of Qdot:myoVa conjugates into pinosomes
and their subsequent release into the cytoplasm, pinosomes were labeled by
the addition of 5 mg/mL FITC-Dextran 500K (Sigma, St. Louis, MO) to the
hypertonic loading medium during the delivery of Qdot:myoVa conjugates
(see above). After a 10 min incubation at 37C, the cells were then washed
three times with hypertonic loading medium and imaged for pinosome encap-
sulation of the Qdot:myoVa conjugates (Fig. 1 A). To confirm that the Qdot:-
myoVa conjugates were released into the cytoplasm upon pinosome lysis, the
cells were then osmotically shocked (see above) and imaged (Fig. 1 B).
To demonstrate that Qdot:myoVa movement was an ATP-dependent
process, intracellular ATP was reduced by inhibiting its synthesis. Cells
were incubated at 37C for up to 30 min in glucose-free MEM with
0.05% sodium azide, an oxidative phosphorylation inhibitor, and 10 mM
2-deoxy-D-glucose, an anaerobic glycolysis inhibitor (all obtained from
Sigma Aldrich). During this treatment, the cells underwent apoptosis as
the intracellular [ATP] fell. Therefore, Qdot:myoVa motion was character-
ized within a 30 min treatment period, given that longer treatments resulted
in significant changes in overall cell morphology and eventual release from
the coverglass surface.
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Cell culture plates were transferred to a Nikon TE2000 inverted microscope
equipped with a PlanApo objective lens (100, 1.49 n.a.) for through-the-
objective TIRF microscopy. Qdots were excited at 488 nm with an argon
laser. Images were obtained at 60 frames/s with 2 2 pixel binning (58.5 nm
pixel resolution) using an intensified CCD camera (XR Mega-S30 running
Piper Control v2.3.14 software; Stanford Photonics, Stanford, CA). Dual-
color, simultaneous imaging was achieved with the use of a dual-view
beam splitter (Optical Insights, Pleasanton, CA). Typically, 1000 images
were recorded for each stack and 20 stacks were recorded per dish of cells.
Image analysis was performed using ImageJ 1.37v (National Institutes of
Health, Bethesda, MD). Qdots were tracked in the x,y visual plane using
SpotTracker 2D (20) to generate motion paths in two dimensions. The
spatial resolution of the imaging system was determined by tracking a
stationary Qdot within a cell over 1000 frames. The 15 nm standard devia-
tion (SD) position error of this Qdot in both the x and y axes reflects the
system’s spatial resolution. Qdot:myoVa conjugate velocities were deter-
mined from the slope of a displacement versus time plot for straight line
motion paths that persisted for more than 20 frames.
The MSD over multiple time intervals is calculated as:
MSDðnDtÞ ¼ 1
N  n
XNn
i¼ 1
ðxiþ n  xiÞ2 þðyiþ n  yiÞ2

;
(1)
where N is the total number of frames in the trajectory, n is the number of
frames for different time intervals over which the MSD is being calculated,
Dt is the time (16.6 ms) between frames, and xi and yi are the positions of the
Qdot in frame i (21). Diffusion coefficients are calculated as one-fourth of
the slope of the MSD versus the time interval relationship when plotted
on linear axes.
For various modes of motion, the relationship between the MSD and the
time interval (nDt) can be generalized by MSD ~ (nDt)a (22), where a is the
‘‘diffusive exponent’’. For an immobile particle, a¼ 0, as displacement does
not change with time. For a randomly moving particle a ¼ 1, and for a
particle moving in a straight line at a constant velocity a ¼ 2. For this study,
the diffusive exponent (a) was determined from the slope of the relationship
between the MSD and time interval (nDt) on log-log axes. The MSD was
calculated using internal averaging, which is also known as ‘‘averaging
over all pairs’’, as this allowed use of the full data set with equal weighting
for each data point (22). For this study, trajectories were composed of 1000
frames each, and MSD analysis was limited to n % 120 or a time interval
of 2.0 s. The short timescale behavior of trajectories, termed a(0–0.2 s), is
characterized by linear fits to the first 12 data points (i.e., up to 0.2 s) of
individual MSD plots on log-log axes.
To compare a(0–0.2 s) values under different experimental conditions,
cumulative probability distributions were plotted. Such an analysis is inde-
pendent of bin width. Cumulative probability distributions were generated
by calculating the probability (i.e., the proportion of the total number of
points in the data set) that any data point would be % x. Fits applied to
the cumulative probability distributions were based on the mean and SD
of the data, assuming a normal (Gaussian) distribution. Because the popula-
tions are well fit as Gaussian distributions, they were compared using
Welch’s two-sample t-test.
Given myoVa’s inherent stepping rate, the imaging rate of 60 frames/s
was sufficient to detect steps generated by a single myoVa motor. These
steps were identified in displacement versus time traces by an unbiased,
statistically based MATLAB software (The MathWorks, Natick, MA)
routine (23). The step dwell time histograms were fit by F(t) ¼ tk2ekt rather
than a single exponential. Since the stepping data were consistent with only
one of the two myoVa heads being Qdot-labeled at its N-terminus, for each
observed step there was an unobserved ‘‘silent step’’ from the unlabeled
head, which occurred at the same rate (6).
The same Qdot:myoVa conjugates delivered intracellularly were charac-
terized for their in vitro run lengths and velocities on single actin filaments inthe single-molecule TIRF assay as described previously (5). However, the
ionic strength of the in vitro assay buffers was increased with 200 mM
KCl to approximate the intracellular ionic strength and to allow more mean-
ingful comparisons to be made between the in vitro Qdot:myoVa velocities
and that measured intracellularly. These in vitro ionic conditions were used
for both the single motor and many motors per Qdot regime. Mean velocities
were compared using Welch’s two-sample t-test, and their variances were
compared using the F-test.
RESULTS
Qdot-labeled MyoVa delivery into cells
Qdot:myoVa conjugates were delivered into COS-7 cells by
osmotic lysis of pinosomes (18,19). This delivery protocol
proved to be quick and effective, and allowed for the treat-
ment of an entire plate of cells (105 cells) in <15 min.
Although intracellular delivery by lipofection was consid-
ered, the Qdot:myoVa conjugates were effectively trapped
within intracellular vesicles. After lipofection was completed
per the manufacturer’s protocol (Lipofectamine 2000; Invi-
trogen, Carlsbad, Ca), the Qdots were colocalized for up to
2 h posttreatment to membrane-bound vesicles, which
were identified using a lipophilic dye (Vybrant DiI; Invitro-
gen, Carlsbad, CA). The resulting data (not shown) suggest
that the Qdot:myoVa conjugates remain internalized within
a vesicular compartment, and that motion of the Qdot:
myoVa conjugates could result from endogenous motors
transporting the encapsulated Qdot cargo.
To test whether a similar situation would occur with pino-
cytosis, FITC-dextran and Qdot:myoVa conjugates were
simultaneously added to the hypertonic loading medium.
As pinosomes formed, both FITC-dextran and Qdot-myoVa
were colocalized within these vesicles (Fig. 1 A). The pino-
somes were then lysed by hypotonic shock and released
their contents, after which a diffuse FITC-dextran haze was
observed throughout the cytosol and numerous Qdot:myoVa
conjugates underwent significant motion (Fig. 1 B; see
Movie S1 in the Supporting Material). During image acqui-
sitions up to 200 s, the Qdot:myoVa conjugates remained
within the ~150 nm thick evanescent TIRF field, suggesting
that these conjugates were restricted to the actin cortex.
The following controls confirmed that Qdots observed in
the TIRF field were conjugated to active myoVa. When bare
Qdots, BSA-conjugated Qdots, or Qdots conjugated to
a nonfunctional, NEM-modified myoVa motor were delivered
into cells, Qdots were infrequently observed in the TIRF field,
but were readily visualized beyond the evanescent field using
far-field illumination (Fig. S1 D, inset). This observation was
confirmed more dramatically by simultaneously delivering
equal amounts of two different-colored Qdot conjugates
(i.e., 565 nm and 655 nm emissions): one conjugated with
BSA and one conjugated with myoVa HMM. After pinocy-
tosis was completed, the motor-conjugated Qdots outnum-
bered BSA-conjugated Qdots within the TIRF field by more
than 600 to one (Fig. S1, A and B). A similar result was ob-
tained when the Qdot colors were reversed (Fig. S1,C andD).Biophysical Journal 97(2) 509–518
512 Nelson et al.FIGURE 2 Modes of motion of various Qdot-labeled
proteins. Example trajectories and ensemble MSD plots
are shown on both linear axes (inset graphs) and log-log
axes (large graphs). The trajectories and their correspond-
ing MSD plots are shown for Qdot:myoVa HMM conju-
gates undergoing random (A) and directed (B) motion, as
well as data from Qdot:BSA (C) and Qdot:myoVa S1
(D) conjugates. The MSD plots are those of ensemble-aver-
aged MSD traces for each of the conjugates. The directed
Qdot:myoVa HMM MSD (n ¼ 5) has an a ¼ 1.9 (dashed
line) indicative of an active process. The Qdot:myoVa
HMM MSD for random trajectories (n ¼ 120) displays
hyperdiffusive behavior at short time intervals (a(0-0.2 s) ¼
1.4, dashed line), which is unique to intact, processive
myoVa HMM, whereas Qdot:BSA (n ¼ 31) and Qdot:
myoVa S1 fragments (n ¼ 61) show random motion at
all timescales, consistent with diffusion, as described by
a ¼ 1.0 (indicated by the dashed lines).Single-particle analysis of Qdot:myoVa motion
Visual inspection of the Qdot:myoVa movements indicated
that most of the trajectories (96%, n¼ 125) appeared random
in nature (Fig. 2 A, Movie S2), although a few trajectories
were clearly directed for greater than a micron (Fig. 2 B,
Movie S3). As a control for a particle undergoing purely
diffusive movements, Qdot:BSA conjugates were also deliv-
ered into cells (Fig. 2 C, Movie S4). To characterize these
movements, individual trajectories were subjected to MSD
analysis. When plotted on linear axes, a parabolic MSD rela-
tionship is indicative of a directed process, such as motor-
driven transport (as in Fig. 2 B, inset). MSD plots originating
from random motion, such as a diffusive process, are linear
(Fig. 2 C, inset), and in this case they yielded a diffusion
coefficient of 0.155 0.12 mm2s1. The MSD relationships
for most of the myoV trajectories plotted on linear axes
(Fig. 2 A, inset) were similar to those of the Qdot:BSA conju-
gates, giving an effective diffusion coefficient of 0.21 5
0.05 mm2s1.
With similar trajectories, MSD plots, and diffusion coeffi-
cients for the BSA and the majority of myoVa conjugates, one
might conclude that the myoVa trajectories are not motor-
driven, but rather are diffusive in nature. The existence of
directed trajectories that are presumably myoVa-dependent
(Fig. 2 B), however, suggests that some component of the
random trajectories may involve myoVa transport. Therefore,
we analyzed the random myoVa trajectories in greater detail,
focusing on timescales that might correspond to the duration
of short myoVa run lengths (i.e., ~0.35 s for a 200 nm runBiophysical Journal 97(2) 509–518length, assuming an in vitro velocity of 580 nm/s; see Table 1).
To emphasize these short timescales, MSD relationships for
the various conjugates were generated for each conjugate
from an ensemble of trajectories and then plotted on log-log
axes (large MSD plots in Fig. 2).
When plotted on log-log axes, the MSD slope defines the
diffusive exponent (a; see Materials and Methods), with
a ¼ 1 indicating random motion (21), as observed for the
Qdot:BSA conjugates (Fig. 2 C; a ¼ 1.1 5 0.1, n ¼ 31),
and a ¼ 2 resulting from a directed process, as with the
Qdot:myoVa conjugate trajectories that were clearly directed
(Fig. 2 B; a ¼ 1.9 5 0.3, n ¼ 5) over all timescales. Of
interest, the MSDs for the apparently random Qdot:myoVa
trajectories are biphasic (Fig. 2 A). An a(0-0.2 s) ¼ 1.4 5
0.2 (n ¼ 120) was obtained for short timescales by plotting
cumulative probability distributions of a for the first 0.2 s
from individual MSD plots (Fig. 3), which is significantly
TABLE 1 Summary of intracellular and in vitro velocities
One motor Many motors p-Value
Velocity þ/
SE (nm/s) n
Velocity þ/
SE (nm/s) n
Intracellular 6045 36 44 5915 40 42 0.959
In vitro 5805 23 67 6045 26 59 0.246
p-Value 0.279 0.747
In vitro data were obtained with 200 mM KCl buffer to approximate the
intracellular ionic strength. Statistical comparisons were made using the
Kolmogorov-Smirnov, which does not assume a parametric distribution of
the data and is independent of bin width (25).
Myosin Va Walks Randomly in Cells 513greater (p < 0.001) than the a ¼ 1.1 5 0.2 (n ¼ 120) for
timescales R 1.0 s. This biphasic MSD suggests that these
random trajectories are not consistent with passive diffusion;
rather, they are hyperdiffusive and presumably the result of
the attached myoVa motor at short timescales.
Does the apparently directed component in the otherwise
random myoVa trajectories arise from myoVa’s association
with some other endogenous motor or process? As a control,
single-headed myoVa S1 fragments conjugated to Qdots were
introduced into cells and then tracked and analyzed (Fig. 2 D,
Movie S5). The S1 fragments are biochemically active but are
incapable of processive movement, which requires a double-
headed motor. As expected, the Qdot:myoVa S1 conjugates
displayed random-appearing trajectories (Fig. 2 D) very
similar to those of the Qdot:BSA conjugates (Fig. 2 C). These
were characterized by linear MSD plots with ana¼ 1.05 0.2
(n ¼ 61; Fig. 2 D), which is no different from the Qdot:BSA
conjugates (p > 0.87), consistent with pure diffusive move-
ment, and by a diffusion coefficient of 0.065 0.04 mm2s1.
The lower diffusion coefficient compared with the Qdot:BSA
conjugates may reflect the transient trapping of the Qdot
within the actin cortex by the attached S1 molecules.
MyoVa stepping and velocities
As a more stringent test to determine whether the observed
Qdot motion was generated by a processive myoVa mole-
cule, we observed the motor’s individual steps within
random trajectories by conjugating the streptavidin-Qdot to
the biotinylated N-terminus of the motor domain (7). Using
the MSD results to guide our subsequent analysis of the
random Qdot:myoVa trajectories, we identified linear
FIGURE 3 Cumulative probability distributions of a(0-0.2 s). At short
timescales (%0.2 s) the initial slope, a(0-0.2 s), of the MSD on log-log
axes was determined for all trajectories associated with the Qdot:myoVa
HMM, Qdot:myoVa S1, and Qdot:BSA conjugates. The Qdot:myoVa
HMM shows hyperdiffusive behavior, with an a(0-0.2 s) shifted to higher
values compared to either the BSA or S1 conjugates, which are close to
1.0 as expected for a diffusive process.segments that persisted %1.0 s (Fig. 4 A) and analyzed the
individual steps at high time (16.6 ms) and spatial (15 nm)
resolution (Fig. 4 B). Using an unbiased statistical algorithm
to identify steps within a noisy displacement versus time trace
(see Materials and Methods), we detected individual 75 5
2 nm (n ¼ 127) steps in short segments that were associated
with 24 separate trajectories (Fig. 5, A and B) and arose
from the population of myoVa molecules that were Qdot-
labeled on only one head (7). Although it is possible that
some of the molecules have both heads that were Qdot-
labeled, the 36 nm spatial separation between heads while
the motor paused (7) prevented us from discerning the motion
of either head, due to the 15 nm spatial resolution. Occasional
backsteps were also observed (Fig. 5 A), as reported recently
for a single myoVa stepping against low resistive loads in the
optical trap (24). The dwell time histogram for the observed
steps (see Materials and Methods for analysis) resulted in
a mean stepping rate of 165 1 s1 (Fig. 5 C).
The mean velocity associated with linear segments as
described above was 604 5 36 nm/s. This velocity is not
significantly different from that observed for the same
construct in the in vitro single-molecule TIRF assay (Table 1).
The intracellular velocity distribution exhibited a 2.7-fold
greater variance (p < 0.0005), which may reflect the more
FIGURE 4 High spatial and temporal resolution tracking of Qdot:myoVa
HMM trajectories in cells. (A) An example x, y position trajectory imaged at
60 frames/s for a total elapsed time of 16.7 s; the inset is an expanded view of
the indicated trajectory segment with individual steps highlighted by circles.
(B) Displacement versus time representation of the same trajectory segment
shown in the inset in A, with the individual steps numbered as in the inset.
Steps are fit as described in Materials and Methods.Biophysical Journal 97(2) 509–518
514 Nelson et al.complex and dynamic nature of the cellular environment. To
confirm that these short runs resulted from an ATP-dependent
process, intracellular ATP levels were effectively reduced by
metabolic inhibition (see Materials and Methods). After this
treatment, the mean intracellular Qdot:myoVa velocity was
reduced 50% (314 5 33 nm/s, n ¼ 20), further supporting
the idea that the random Qdot:myoVa trajectories have an
active, ATP-dependent component.
Although we observed a single myoVa stepping proces-
sively, as described above, intracellular cargo transport
may involve multiple motors sharing this responsibility
(14). To mimic multiple-motor transport, we used a myoVa
HMM construct that was biotinylated at the C-terminus,
which allowed the attachment of up to four motors (16) to
a single streptavidin-conjugated Qdot (see Materials and
Methods). The in vitro run lengths for these Qdot-myoVa
conjugates (1321 5 116 nm, n ¼ 59) were nearly twice as
long as that for a single motor (8015 56 nm, n ¼ 67), con-
firming that multiple motors were attached to the Qdot
(Table 1). When these multiple-motor Qdot conjugates
were delivered into cells, the intracellular velocities were
the same as that exhibited by a single motor, as was the
case in vitro (Table 1).
FIGURE 5 Intracellular stepping of MyoVa. (A) Two displacement
versus time traces from Qdot:myoVa HMM conjugates derived from trajec-
tories that are random in appearance (see Figs. 2 A and 4 A) with steps
identified by the step finding algorithm (see Materials and Methods). A
backstep is apparent in the lower trace. (B) A step size histogram (755 2 nm
(mean5 SE), n ¼ 127) for steps derived from linear segments of random-
appearing trajectories. (C) The dwell time histogram was fit to F(t) ¼ tk2e-kt
(see Materials and Methods) to derive a stepping rate of k ¼ 165 3 s1.Biophysical Journal 97(2) 509–518DISCUSSION
MyoVa’s processive stepping and its ability to maneuver
through actin filament intersections in vitro (4) may
contribute to this unconventional myosin’s capacity to trans-
port intracellular cargo. MyoVa’s role in normal cellular
function is highlighted by human myoVa gene mutations
that lead to Griscelli syndrome, a disorder characterized by
albinism and either neurological impairment or immunodefi-
ciency (26,27). Although its ability to transport cargo as it
steps processively has been characterized extensively
in vitro, direct evidence of this within cells is lacking. To
address this, we introduced Qdot-labeled myoVa into
mammalian COS-7 cells by pinocytosis and characterized
the intracellular motion paths associated with single myoVa
motors using TIRF microscopy, with imaging limited to the
subplasmalemmal actin cortex. Using this approach, we
observed the individual steps of a single myoVa HMM
motor as it processively carried its Qdot cargo through the
actin cytoskeleton. In addition, the velocity of cargo trans-
port was independent of the number of attached myoVa
motors regardless of whether transport was characterized
in vitro on single actin filaments or within the complex intra-
cellular environment.
Characteristics of intracellular MyoVa motion
The enrichment of Qdot:myoVa HMM conjugates within the
TIRF field of illumination (see Results) after their release
from pinosomes suggests that the actin cortex may act as a
spatial filter to confine active Qdot:myoVa HMM conju-
gates. Of interest, the majority of motion paths associated
with these conjugates were random in appearance (Fig. 2 A),
with only an occasional directed trajectory (Fig. 2 B). Given
that the cortical actin meshwork is composed of numerous
actin filament intersections and Arp2/3 junctions (28), the
random trajectories may arise from a myoVa motor taking
a ‘‘random’’ walk along this complex actin network. This
is supported, as discussed below, by 1), a detailed character-
ization of trajectories through MSD analysis; 2), the detec-
tion of individual myoVa steps within segments of random
trajectories; 3), the decreased velocity of Qdot:myoVa
HMM motion at lowered ATP concentration; and 4), Monte
Carlo simulations of myoVa processive transport along
a defined actin filament network.
MSD analysis
MSD analysis provides a means of distinguishing between
particle motions that are thermally driven and those that are
driven by directed movements generated by a molecular
motor. When plotted on log-log axes, the MSD slope (a) is
characteristically 1.0 for random motion and 2.0 for directed
transport (21). The MSD plots of Qdot:myoVa HMM conju-
gates had a significantly (p < 0.001) steeper slope (a ¼ 1.4)
at short timescales (i.e., %0.2 s; Figs. 2 and 3), but were
Myosin Va Walks Randomly in Cells 515comparable to BSA or S1 at longer timescales (a ¼ 1.1;
Fig. 2). Thus, the random Qdot:myoVa HMM trajectories
cannot be described as purely diffusive; rather, they must
have a directed component contributing to motion at short
timescales. In further support of this, Qdot:myoVa S1 conju-
gates, which show no appreciable actin-binding or processive
behavior in vitro (see Results), exhibit MSD with an a similar
to that of the diffusive Qdot:BSA conjugate (Figs. 2,C andD,
and 3). Of interest, a similar crossover in MSD plots, going
from enhanced (a ¼ 1.5) to thermally based random motion
(a ¼ 1), was reported for microsphere trajectories in SV80
cells (29). The authors concluded that the enhanced diffusion
could be attributed to microtubular-based motor transport in
the perinuclear microtubule meshwork, since microsphere
trajectories become purely diffusive after treatment with no-
codazole to depolymerize microtubules.
MyoVa intracellular stepping and velocities
One trivial explanation for the directed component in the
Qdot:myoVa HMM MSD is that the complex associates
with an endogenous myosin motor and becomes its cargo.
If so, Qdot displacements would reflect the stepping
behavior of the endogenous motor. However, the large
sequential 75 nm steps observed in short segments of the
random Qdot:myoVa HMM trajectories (Figs. 4 and 5) are
only consistent with a processively stepping myoVa mole-
cule labeled on one head (7). If the labeled myoVa were
the cargo of an endogenous myosin, steps of half that size
(~37 nm) would be expected, reflecting displacement of
the endogenous motor’s center of mass.
The observed 16 s1 stepping rate is similar to the ADP-
release rate that is rate limiting for ATP hydrolysis and proc-
essive stepping in vitro (12,30,31). Thus, the average velocity
for this stepping behavior is 600 nm/s, assuming that the
motor’s center of mass is displaced by half the distance trav-
eled by each of its heads (i.e., 37.5 nm). This velocity is
similar to the mean velocity (6045 36 nm/s) measured for
short, straight-line segments within random trajectories
where individual steps were not easily detected. The intracel-
lular velocities are in excellent agreement with the in vitro
velocity determined for these same Qdot:myoVa conjugates
under conditions mimicking intracellular ionic strength
(Table 1). The reduction in intracellular velocities observed
after metabolic poisoning to lower the cellular ATP content
is also consistent with active stepping by myosin.
If Qdot:myoVa conjugates were prone to perpendicular
motion relative to the optical plane, it would have been
impossible to observe individual motors for up to 200 s
within the ~150 nm TIRF field of illumination. Additionally,
the two-dimensional (2D) motion projections visualized here
would tend to underestimate both the motor’s velocity and
step size. Since these measurements were identical for the
in vitro (7) and intracellular environments, we feel confident
that the the 2D particle tracking is valid because the actincortex effectively becomes 2D as it lies parallel to the cell
surface in contact with the coverslip.
Taken together, these data provide strong evidence that
the observed Qdot motion (at least for portions of the random
trajectories) is due to a single myoVa molecule stepping
along actin tracks within the cell cortex.
Monte Carlo simulations of MyoVa motion
trajectories
To understand the extent to which myoVa contributes to the
observed motion, we developed a simple model (see the
Supporting Material for details) to simulate four potential
scenarios of Qdot:myoVa motion constrained to the visual
plane, in which the motor 1), steps processively along
a single actin filament; 2), steps processively along an actin
network containing intersections; 3), steps processively
along an actin network 50% of the time and freely diffuses
the other 50%; or 4), only undergoes pure diffusion.
The basic assumptions in this model are that 1), the Qdot
is transported by a single processive myoVa HMM with
experimentally determined step size and dwell time distribu-
tions (12,24,30,31); 2), when confronted with an actin-actin
intersection, the probability that the motor turns or continues
through the intersection is defined by previous in vitro
studies (4); 3), the randomly oriented actin filament mesh-
work (Fig. 6 B) is defined by a characteristic distance (i.e.,
125 nm) between actin-actin intersections based on EM
images of the cortical actin cytoskeleton (28,32); and 4),
the time and spatial resolutions for the Qdot position are
defined by the experimental system used in this study.
With these simple assumptions, 1000 simulated trajectories
for the four hypothetical cases described above were gener-
ated and an ensemble-averaged MSD was calculated and
plotted on log-log axes (Fig. 6 C). In addition, the MSD
slope for short timescales (up to 0.2 s; a0-0.2 s) was fit and
a cumulative probability plot was generated (Fig. 6 D).
Fig. 6 A shows a portion of a displacement versus time
trace from a simulated trajectory for a myoVa moving
processively along a straight actin filament (case 1), as seen
in the single-molecule in vitro TIRF assay (4,5). The
ensemble-averaged MSD plot was described by an a¼ 1.85
0.03 over all timescales (Fig. 6, C and D), close to the ex-
pected value of 2 for a directed process. The slightly lower
a for the simulation is largely due to the dwell time of the
motor as it steps along the actin filament. On closer inspec-
tion, the motor’s stepping behavior, even under ideal condi-
tions, can be described as periods of constrained motion
(i.e., during its dwell time) interspersed with sudden 75 nm
steps. By MSD analysis, constrained motion is described
by an a < 1. Thus, the existence of apparent constrained
motion as the motor pauses between steps results in a
depressed MSD slope, particularly at the shortest timescales.
MSD values are also depressed by the modeled uncertainty of
the myoVa position based on the spatial resolution of theBiophysical Journal 97(2) 509–518
516 Nelson et al.FIGURE 6 Monte Carlo simulation
of MyoVa modes of motion. (For details
of the model simulations, see Discussion
and Supporting Material.) (A) Simula-
tion of myoVa processively stepping
on single, straight actin filament, as
seen in single-molecule TIRF assays.
The step detection algorithm recovers a
mean step size of 705 23 nm (n¼ 139)
similar to the 72 nm step size used in
generating the trajectories. (B) Simu-
lated myoVa HMM trajectory of a proc-
essive random walk through a complex
actin filament network (see filament
tracing) is described by a highly convo-
luted trajectory. Individual steps are
apparent during trajectory segments
and are similar to experimental results.
A tracing of the cortical actin network
taken from Svitkina et al. (28) is used
to define the distance between actin-
actin intersections. (C) Ensemble MSD
analysis on log-log axes of 1000 simula-
tions as in B (case 2, solid line) reveals
a relationship with an initial slope of
1.3, which falls to 1.0 at longer time-
scales. MSD for simulations of a purely
diffusive Qdot:myoVa (case 4, dotted
line) has a slope, a, of 1.0 at all time-
scales, as expected for a diffusive
process. For processive trajectories on a single straight actin filament, the MSD simulation results ina¼ 1.8 at all timescales (case 1, dashed line). (D) Cumulative
probability distribution of a(0-0.2 s) for trajectory simulations: case 1, processive movement of straight actin filament; case 2, processive movement on actin fila-
ment network as in B; case 3, processive movement on actin network 50% of the time and purely diffusive for the remaining 50%; case 4, purely diffusive.optical system (see Fig. S4). At the opposite extreme (case 4),
the simulated trajectories for a purely diffusive Qdot:BSA
conjugate (trajectory not shown) give a linear MSD plot over
all timescales (Fig. 6 C) but with an a0-0.2 s¼ 1.05 0.1, as ex-
pected for a diffusional process (Fig. 6 D). For case 2, in which
the motor steps processively on a randomly oriented actin
filament network, the simulated trajectory is extremely convo-
luted, arising from myoVa’s propensity to turn at an intersec-
tion (Fig. 6 B). These trajectories are similar to those observed
experimentally, having short segments with detectable 75 nm
steps. In fact, the ensemble-averaged MSD plot (Fig. 6, C and
D) shows a biphasic nature similar to that of the plot observed
experimentally, with a simulated a0-0.2 s ¼ 1.35 0.1 at short
timescales and 1.0 5 0.3 at longer timescales. Case 2 alone
provides significant insight to the interpretations of an MSD
relationship. In this case, we assume that the myoVa never
leaves the actin tracks and thus diffusional processes do not
contribute to the trajectory. Without prior knowledge, the
resultant trajectory and MSD could have been interpreted as
having a significant diffusive component given its a ¼ 1 at
longer timescales. Finally, for case 3, in which the motor
spends half of its lifetime processively stepping while the other
half is in pure diffusion, the a0-0.2 s ¼ 1.25 0.1 at short time-
scales, falling to 1.0 at longer timescales (Fig. 6 D).
Two important insights were derived from this modeling
effort: 1), at long timescales, MSD analysis cannot distinguishBiophysical Journal 97(2) 509–518between a Qdot-labeled motor undergoing pure diffusion or
one that is processively stepping along a randomly oriented
actin filament network; and 2), at short timescales (~0.2 s),
the reduction ina from the expected value of 2 for a processive
motor is dependent on the distance between actin-actin inter-
sections, the probability that the motor will turn at an intersec-
tion, and the proportion of the motor’s lifetime that will be
spent undergoing diffusion (see Supporting Material). Thus,
in light of the model, the experimentally obtained a0-0.2 s ¼
1.4 5 0.2, with its lower estimate of a0-0.2 s ¼ 1.2 (i.e., 1
SD), suggests that the myoVa motor spends at least half of
its lifetime taking a processive random walk along the actin
cytoskeleton.
In vitro versus cellular velocities
Intracellular cargo transported by myoVa, such as melano-
somes, may have as many as 60 attached motors (14). If
multiple motors on the cargo surface can simultaneously
interact with the actin track, the transport velocity could
vary with the number of engaged motors. Kural and co-
workers (8) proposed that the unusually high velocities for
peroxisome transport by kinesin in cells compared with
in vitro estimates for a single kinesin motor may result
from multiple motors sharing the workload. More recently,
Yoo and co-workers (33) delivered Qdot:kinesin conjugates
into cells via a lipid-based internalization protocol, and also
Myosin Va Walks Randomly in Cells 517reported higher velocities for these motors compared with
in vitro measurements. The fact that both groups reported
higher intracellular velocities for kinesin transport suggests
that movements of the microtubular track, whether thermally
based or derived by interactions of other motors with the
cytoskeletal track, may have contributed to the high speeds
of cargo movement (34–36).
Here we took advantage of our Qdot-labeling strategy to
compare single and multiple myosin motor transport in vitro
and within cells. The velocities for single and multiple myoVa
motor transport were the same for both in vitro and inside cells
(Table 1). This result suggests that the intracellular environ-
ment may not pose a physical barrier to cargo transport (37),
at least for cargo with dimensions comparable to the ~20 nm
diameter Qdot. Similarly, there is no evidence that cargo
velocity powered by multiple kinesin motors within cells is
enhanced above the capacity inherent to a single motor (33,38).
CONCLUSIONS
Here we show by single-molecule imaging that a myoVa
motor can processively transport cargo, in this case a Qdot,
within a cell with stepping dynamics similar to that observed
in vitro. However, it remains unclear how a myoVa under-
going a random walk along the cytoskeleton can deliver
cargo effectively to destinations near the cell periphery. It
should be noted that with TIRF imaging, the myoVa trajec-
tories are observed only within the actin cytoskeleton that
resides ~150 nm beneath the cell membrane. The rarity of
Qdots departing the evanescent field and returning to the
cell interior while moving several microns within the plane
of the cell membrane suggests that the Qdot:myoVa conju-
gates were essentially at their destination. Perhaps their
random paths might have been expected since the Qdots
do not possess the necessary accessory proteins to target
the cargo to its destination (39). However, provided that
there is a component of myoVa processive movement within
the trajectory, and that the overall orientation of actin
network is such that the actin filament’s barbed ends are
pointed toward the periphery (40), the myoVa transporters
should ultimately be able to deliver their cargo to destina-
tions near the cell membrane.
Using the approach described here, it may be possible in
future studies to characterize the targeting of motors to cargo
in real time, as well as to determine how a given motor switches
between actively transporting its cargo to being a passenger on
the same cargo. Such studies, in combination with attempts to
reconstruct an in vitro cytoskeleton in three dimensions, will
ensure that significant progress can be made in understanding
the complex nature of intracellular cargo transport.
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